Institute of Institute of Hematology & Blood Diseases Hospital ( Chinese Academy of Medical Sciences)
Institute of Institute of Hematology & Blood Diseases Hospital ( Chinese Academy of Medical Sciences)
Tianjin, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-08-03 | NCT07743112 |